Clinical trial
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
NCT00302744 · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Other · Completed
Key facts
| NCT number | NCT00302744 |
|---|---|
| Title | Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety |
| Official title | Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety |
| Lead sponsor | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Other |
| Collaborators | Heffter Research Institute |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Anxiety |
| Intervention type | Diagnostic Test, Drug, Other |
| Interventions | Psilocybin (drug), Niacin, MRI |
| Enrollment | 12 |
| Start date | Apr 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Mar 14, 2006 |
| Last update posted | Mar 13, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: